Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 474-080-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 6.-20.11.2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- -
- EC Number:
- 474-080-4
- EC Name:
- -
- Cas Number:
- 76801-93-9
- Molecular formula:
- C14H18I3N3O6
- IUPAC Name:
- 5-amino-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
- Reference substance name:
- Unknown impurities
- Molecular formula:
- Not available
- IUPAC Name:
- Unknown impurities
- Test material form:
- solid
Constituent 1
impurity 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 00104016
- Expiration date of the lot/batch: 12/2020
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
- Stability under test conditions: Stable
In chemico test system
- Details on the study design:
- PRINCIPLE OF TEST METHOD
The DPRA is a chemistry-based assay. Nucleophile-containing synthetic peptides (cysteine peptideAc-RFAACAA-COOH; lysine peptide- Ac-RFAAKAA-COOH) are used to screen for skin sensitisation potential by measuring peptide depletion following incubation with allergens and non-allergens.
Synthetic heptapeptides containing either cysteine or lysine are incubated with the test item for 24 hours. Depletion of the peptide in the reaction mixture is measured by high pressure liquid chromatography (HPLC) using UV detection. Average peptide depletion data for cysteine and lysine are then calculated.
SOLVENT SELECTION
Solvent selection was performed according to DB-ALM (INVITTOX) Protocol No.154: Direct Peptide Reactivity Assay (DPRA) for Skin Sensitisation Testing, 2012. According to this protocol, acetonitrile is the preferred solvent for test chemicals. An approximately 100 mM solution of ATIBA-A in acetonitrile was prepared. Test item was not dissolved completely. Therefore, been prepared 100 mM solution of ATIBA-A in ultra pure water, then in isopropanol and acetone, but test item was not dissolved completely.
Further test item was attempted to dissolve in 300 microliters of dimethyl sulfoxide and diluted the resulting solution with 2700 microliters of acetonitrile. Vial was placed in sonicating bath for 1 minute, but item was not dissolved completely.
Further test item was attempted to dissolve in 1500 microliters of dimethyl sulfoxide and diluted the resulting solution with 1500 microliters of acetonitrile. Vial was placed in sonicating bath for 1 minute, but item was not dissolved completely.
So test item was attempted to dissolve in 3000 microliters of dimethyl sulfoxide. Vial was placed in sonicating bath for 5 minutes, item was dissolved completely. However, it is important to note that DMSO may lead to peptide dimerisation and as a result, it may be more difficult to meet the acceptance criteria.
As a last resort, was tested lower soluble concentration of the test item. Was prepared 50mM solution of ATIBA-A dissolved in 1500 microliters of dimethyl sulfoxide and diluted the resulting solution with 1500 microliters of acetonitrile. Vial was placed in sonicating bath for 1 minute, item was dissolved completely. In the case of negative prediction (lack of reactivity), no firm conclusion should be drawn.
PREPARATION OF TEST ITEM SOLUTION
The weighed amount of ATIBA-A (approximately 213.6 mg) was dissolved in 3 ml of dimethyl sulfoxide.
The weighed amount of ATIBA-A (approximately 106.8 mg) was dissolved in 1500 µl of dimethyl sulfoxide and diluted with 1500 µl acetonitrile.
REFERENCE CONTROLS AND CO-ELUTION CONTROL
Three types of "Reference Controls" were included in this study. Reference Control is a peptide solution where the test chemical is replaced by the solvent used to dissolve it.
Reference Control A was made with acetonitrile and used to verify the accuracy of the calibration curve for peptide quantification.
Reference Control B was made with acetonitrile and its replicates are injected in the beginning and in the end of the experimental run to verify the stability of the peptide over the analysis time.
Reference Controls C was made with acetonitrile and DMSO/ACN (1:1) (solvent used to solubilise the test item). They are used to verify that the solvent does not impact the Percent PeptideDepletion. The appropriate Reference Controls C for each chemical are used to calculate Percent Peptide Depletion.
Co-elution control was constituted by the test item alone without the addition of peptides. Instead of the addition of peptides, the appropriate amount of buffer was added. The co-elution test serves to verify that the test item does not have the same retention time and does not absorb at 220 nm as the Cysteine and Lysine peptides.
PREPARATION OF PEPTIDE STOCK SOLUTION
The necessary amount of peptide was estimated. For each analysis with addition of peptide, 800 µl of stock solution is needed. 25 ml of the stock solution of Cysteine or Lysine peptide (0.667 mM) was prepared.
ANALYSES
Liquid chromatograph: Shimadzu Nexera LC-30AC with DAD
Column: Agilent Zorbax SB-C18, 100x2.1 mm, 3.5µm
Precolumn: Phenomex security guard C18, 4.0 x 2.0 mm
Mobile phase A: 0.1% Trifluoracetic acid in water
Mobile phase B: 0.085% Trifluoracetic acid in acetonitrile
Time programmer:
0 min 10 % B
10 min 25 % B
11 min 90 % B
13 min 90 % B
13.5-20 min 10 % B
Column temperature: 30 °C
Sample temperature: 25°C
Flow rate: 0.35 mL/min
Injection volume: 10 μL
Detection: 220 nm, 258 nm
Results and discussion
- Positive control results:
- Cinnamaldehyde was used as positive control at a concentration of 100 mM in acetonitrile.
The mean percent peptide depletion value at 220 nm for the positive control Cinnamaldehyde is 77.2 % for the Lysine peptide. This was due to the ambiguous integration of the lysine peptide peak after incubation with Cinnamaldehyde. Therefore, the peak area of lysine peptide was also evaluated at 258 nm. The mean percent peptide depletion value at 258 nm for the positive control Cinnamaldehyde is 66.2 % for the Lysine peptide. This does not affect the outcome of the study, as the test item appears to be negative.
In vitro / in chemico
Results
- Key result
- Run / experiment:
- other: 1
- Parameter:
- other: mean of percent Cysteine and percent Lysine depletion values
- Value:
- 0
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- The following criteria should be met for a run to be considered valid:
a) the standard calibration curve should have an r2˃0.99
b) the mean percent peptide depletion value of the three replicates for the positive control Cinnamaldehyde should be between 60.8% and 100% for the Cysteine peptide and between 40.2% and 69.0% for the lysine peptide and the maximum standard deviation (SD) for the positive control replicates should be <14.9% for the percent Cysteine depletion and <11.6% for the percent lysine depletion
c) the mean peptide concentration of reference controls A should be 0.50±0.05 mM and the coefficient of variation (CV) of peptide peak areas for the nine reference controls B and C in acetonitrile should be <15.0%. If one or more of these criteria is not met the run should be repeated.
The following criteria should be met for a test item results to be considered valid:
a) the maximum standard deviation for the test item replicates should be <14.9% for the percent Cysteine depletion and <11.6% for the percent lysine depletion
b) the mean peptide concentration of the free Reference controls C in the appropriate solvent should be 0.50±0.05 mM.
Any other information on results incl. tables
RESULTS EVALUATION
Since the use of DMSO as the sample solvent led to its significant dimerization, the results of determination mean of cysteine and Lysine percent depletion were not included in the final assay.
Since the test chemical was not dissolved in a suitable solvent at a concentration of 100 mM, the concentration of the test chemical was reduced to half (50 mM) a test item was prepared by adding 1500 µl DMSO to the sample and diluted the resulting solution with 1500 µl ACN.
In this case too, the effect of dimerization was apparent. To obtain approximate results, but was neglected.
Based on the results obtained, the Cysteine 1:10/Lysine 1:50 prediction model was used.
Determining the reactivity class and the DPRA prediction forATIBA-A
Test item |
CAS No.: |
Mean of Percent Cysteine depletion % |
Mean of Percent Lysine depletion % |
Mean of Cysteine and Lysine Percent depletion % |
Reactivity Class |
DPRA prediction |
ATIBA-A |
76801-93-9 |
-6.7 |
-2.9 |
0.0 |
No reactivity |
Negative |
The mean of Cysteine and Lysine percent depletion values was0.0. Thetest item ATIBA-A was included in the reactivity class – no reactivity and was determination as negative in the DPRA prediction. Due to the fact that the test substance does not dissolve in any solvent at the recommended concentration of 100 mM and in the case of negative prediction (lack of reactivity), no firm conclusion can be drawn.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- All study acceptance criteria have been successfully met.
The test item, ATIBA-A, has been found negative in the DPRA prediction; it was assigned to reactivity class “no or minimal reactivity” for both peptides.
Due to the fact that the test item does not dissolve in any solvent at the recommended concentration of 100 mM and due the fact that the test item was negative in the DPRA prediction, no firm conclusion about covalent binding of test item to proteins can be drawn.
The data generated with this test should be considered in the context of integrated approached such as IATA, combining the result with other complementary information, e.g. derived from in vitro assays addressing other key events of the skin sensitisation AOP. - Executive summary:
The purpose of the test is to contribute to the evaluation of the skin sensitisation potential of ATIBA-A. The study is a part of test item hazard evaluation for registration of industrial chemicals.
The test was performed according to OECD TG 442C, In Chemico Skin Sensitisation: Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins (Adopted: 18 June 2019).
The test item, ATIBA-A, has been found negative in the DPRA prediction; it was assigned to reactivity class “no or minimal reactivity” for both peptides.
Due to the fact that the test item does not dissolve in any solvent at the recommended concentration of 100 mM and due the fact that the test item was negative in the DPRA prediction, no firm conclusion about covalent binding of test item to proteins can be drawn.
The data generated with this test should be considered in the context of integrated approached such as IATA, combining the result with other complementary information, e.g. derived from in vitro assays addressing other key events of the skin sensitisation AOP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.